These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37620427)

  • 1. Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men.
    Zhu M; Babar M; Hawks-Ladds N; Tawfik MM; Loloi J; Labagnara K; Sayed R; Tang K; Salami A; Singh S; Singh J; Ines M; Iqbal N; Ciatto M
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):109-115. PubMed ID: 37620427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world evidence with The Rezūm System: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes.
    Ines M; Babar M; Singh S; Iqbal N; Ciatto M
    Prostate; 2021 Sep; 81(13):956-970. PubMed ID: 34254333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four years of real-world sexual function outcomes after Rezum therapy in men with and without baseline erectile dysfunction.
    Hawks-Ladds N; Cook R; Babar M; Zhu M; Schulz A; Loloi J; Masoud Z; Singh J; Jamil H; Sayed R; Ines M; Ciatto M
    J Sex Med; 2024 Sep; 21(9):777-786. PubMed ID: 39084676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
    Bassily D; Wong V; Phillips JL; Fraiman M; Bauer R; Dixon CM; Wong NC
    Prostate; 2021 Oct; 81(14):1049-1054. PubMed ID: 34287992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review.
    Babar M; Loloi J; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2022 May; 14(3):140-154. PubMed ID: 35233955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rezum Outcomes in Relationship to Number of Injections: Is Less More?
    Babar M; Loloi J; Azhar U; Tang K; Ines M; Singh S; Iqbal N; Ciatto M
    J Endourol; 2023 Feb; 37(2):157-164. PubMed ID: 36112665
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk Factors and Real-World Short-Term Outcomes of a Failed Trial of Void After Rezum Therapy in a Multiethnic Population.
    Babar M; Labagnara K; Loloi J; Tang K; Ines M; Singh S; Iqbal N; Ciatto M
    J Endourol; 2023 Jan; 37(1):67-73. PubMed ID: 36029212
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
    Bausch K; Zahiti L; Schrutt M; Wetterauer C; Halbeisen FS; Ebbing J; Seifert HH
    World J Urol; 2023 Jun; 41(6):1605-1612. PubMed ID: 37140664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
    Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
    Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
    Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
    Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis.
    Miller LE; Chughtai B; McVary K; Gonzalez RR; Rojanasarot S; DeRouen K; Bhattacharyya S
    Medicine (Baltimore); 2020 Jul; 99(30):e21365. PubMed ID: 32791742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the Rezum system for the treatment of catheter-dependent urinary retention: Three-year real-world outcomes in a multimorbid, multiethnic population.
    Babar M; Masoud Z; Labagnara K; Loloi J; Sayed R; Singh S; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2023 Jul; 15(4):148-153. PubMed ID: 37190924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.
    Alegorides C; Fourmarier M; Eghazarian C; Lebdai S; Chevrot A; Droupy S
    Prog Urol; 2020 Oct; 30(12):624-631. PubMed ID: 32826195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.